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During today's presentations, we have heard about existing and new technologies
that can expand the scope of newborn and genetic screening. My role as a genetic
counselor in this sphere involves assisting individuals andfamilies as theygo through
the process of confirmation of some screening results, follow-up care, and family
adjustment. In addition, I counsel families who are making decisions about DNA-
based carrier testing, agroup facingconcerns illustrative ofmanyimportant issues in
expanded populationgenetic screening. Iwould like to present some thoughts about
the evolution of these roles as screening expands. These ideas will touch on family
and societal issues, public policy concerns, education, and provision of genetic
services.
As we have heard, new molecular screening techniques can identify not only
affected individuals, but also carriers of an increasing number ofgenetic conditions.
These techniques must be applied in such a way as to provide information in a
maximally beneficial fashion. For example, early diagnosis of cystic fibrosis would
allow early therapeutic intervention, thus maximizing outcome for the patient. A
carrier who might be identified by the same test gains no medical benefit from the
knowledge ofcarrierstatus, however, and, infact, mayexperience adverse psycholog-
ical consequences if the information is learned at an age when it cannot be
reasonably understood or assimilated. Such an individual may have decided against
screening, an option not available if screening is performed in the newborn period
[1]. Care must be taken not to disrupt this person's privilege ofself-determination.
AsAttorneyAndrews stated, geneticscreening also hassignificant implications for
extended family members. In the cystic fibrosis example, an individual's population
carrier risk of /25 is increased to 1/2 if a sibling is found to be a carrier for the disease.
Abalance mustbe struckbetween anindividual's knowledge ofa significant increase
in genetic risk and the screened sibling's right to confidentiality [2,3,4]. Another
consideration, as Dr. McCabe explained this morning, would be the population of
couples where one member is identified as a carrier of cystic fibrosis and the other
has a negative carrier test. Since this negative test is not 100 percent accurate
because all mutations cannot at present be detected, the psychological ramifications
ofthis situation could be significant.
Children awaiting placement for adoption represent an additional group of
individuals potentially affected by expanded genetic screening [4,5]. Knowledge of
carrier status or susceptibility to later-onset conditions of medical importance may
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decrease a child's chance of being adopted. Moreover, identification of such a child
as a carrier recalls the previous points regarding notification of biologic family
members at increased genetic risk, with the added factor of the confidentiality
surrounding the adoption process. Formal public policies regarding these concerns
may soon become necessary.
Additional public policy issues that will need to be considered include: the
equitable availability of or access to genetic screening, implementation of screening
based on appropriate cost/benefit analysis, readiness of a test for population
screening as discussed for cystic fibrosis deletion analysis, mandatory versus optional
screening, and the possible ramifications of screening pertaining to genetic discrimi-
nation and stigmatization [4,5]. The controversies surrounding human immunodefi-
ciency virus screening illustrate the difficulty in successfully negotiating these
questions.
As Dr. McCabe mentioned earlier, today's discussions on the possibility of
expanded genetic screening highlight the need for additional professionals with
various levels of training to provide genetic services [6]. Confirmation testing and
follow-up care for individuals identified by screening are extremely time-consuming.
From the perspective of genetic counselors in clinical settings where these services
are provided, this development is seen as an increase in the number of patients with
significant psychosocial as well as medical needs, who require a substantial time
investment. Furthermore, techniques which identify unaffected carriers of genetic
disease define a large additional population now in need of services. For example,
sickle-cell anemia screening revealed 2,000 individuals with sickle trait in the state of
Michigan in 1988, and, in the same year, 20,000 such individuals were identified in
states in the Southeastern Regional Genetics Group [7]. The 15 existing genetic
counseling training programs cannot adequately provide qualified individuals for all
the currently available positions nationwide, not to mention the increased load
generated by new screening programs. An upcoming National Society of Genetic
Counselors position paper from a conference on this topic recommends increasing
both the number of training programs and the number of trainees per program [7].
To some counselors, however, this solution is a two-edged sword, because positions
in which a genetic counselor utilizes all of his or her skills will become more limited.
In the sickle-cell example, a counselor could be employed to provide trait counseling
to all identified carriers, but the repetitive nature of the work would soon become
tedious and uninteresting. These routine, but essential, functions ofgenetic counsel-
ingwill need to be incorporated into multifaceted positions, which also include more
challenging components. Moreover, the further development and use ofsupplemen-
tal teaching materials, for example, videotapes and informational booklets such as
those provided today, can be coupled with more individual counselor attention when
appropriate.
A recent development designed to alleviate some of these difficulties involves the
use of individuals who are trained to provide counseling around one disease
state-so-called single-gene counselors [8]. While such individuals may be able to
function in a limited fashion to aid in the provision of genetic services, some
questions surrounding theiruse must firstbe addressed. These include establishment
oftraining standards, means to assess competence, and adequate supervision byfully
trained genetic professionals [7]. In addition, the role ofsingle-gene counselors must
be clearly defined for patients. Nurses and other health professionals have also been
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providing genetic counseling in areas where the supply of traditionally trained
counselors is inadequate. Often, however, they do not have the genetics training to
deliver all ofthe services routinelyprovided bymaster's-level genetic counselors.
The role ofthe primary provider is also likely to expand as new genetic screening
tests are implemented [9]. Discussion about whether to have testing done, referral
for additional counseling and testing, and, in some instances, consideration of
options once results are available may all become routine parts of primary care
practice. A broader training at the medical school level, as well as more intensive
efforts in continuing education surrounding these issues, may be necessary [5].
Finally, implicit in the availability of expanded genetic services is the need for
increased education ofthe general public about theiruse. Genetic counselors should
play an integral role in all ofthese educational efforts.
In summary, implementation ofnewnewborn and genetic screening testswill raise
many questions and place new stresses on the delivery system for genetic services.
The issues that I have presented will need careful consideration prior to the
initiation ofsuch new tests.
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